Bioethics plays a critical role in the advancement of human health by providing ethical and just applications of new science, technological and therapeutic breakthroughs. From our earliest days, ethical decision-making that puts people first has guided our business. Today, Johnson & Johnson is collaborating to advance bioethical standards across the industry to meet and exceed the changing needs of future generations.
Healthcare is undergoing unprecedented change on every front. We are witnessing advancements in medicine, science, technology and data analytics, as well as patients and consumers who are increasingly educated and engaged in their own care.
Most people obtain a medication when their doctors write a prescription. That prescribed medication has been studied, evaluated and approved by a national regulatory authority, such as the U.S. Food and Drug Administration (FDA). However, for patients with very serious and/or life-threatening conditions that have already tried all currently available treatment options, an investigational medication – or one that is still being studied in clinical trials – may be their best option.
The Office of the Chief Medical Officer (OCMO) is a global, functionally independent group responsible for leading medical safety and championing bioethical principles across Johnson & Johnson’s Pharmaceutical, Medical Device and Consumer Health sectors. Johnson & Johnson’s OCMO is constantly reviewing, monitoring and making decisions regarding the safety of our products through people-driven processes, initiatives and policies that are reinforced by a single medical safety standard, to which all our products are held.
With health insurance enrollment season in full swing, you may be researching which plan to get—and signing those data disclosure forms. But have you ever wondered how some of that info is used once you sign on the dotted line?
With the summer season in full swing, we asked Edwin Kuffner, M.D., Chief Medical Officer for Johnson & Johnson Consumer Inc., to share his expert advice for soothing red skin—and, better yet, keeping it protected from burns.
Established in 2013, Johnson & Johnson’s Office of the Chief Medical Officer (OCMO) is a global team encompassing safety colleagues from across all sectors of Johnson & Johnson. Functionally independent from commercial interests, we focus entirely on the safety of all products across the Johnson & Johnson Family of Companies. Our approach is reinforced by a cutting-edge single medical safety standard to which all of our products are held.
The company's mission is to care for the world—one person at a time. Just ask Chief Medical Officer Joanne Waldstreicher, M.D., who's been leading the charge to improve the process by which very sick patients may apply for access to investigational medications.